Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer

NCT06007092 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Carcinoma
Adult Disease

Interventions

BIOLOGICAL: HPVDC injection level dose 1
BIOLOGICAL: placebo injection level dose 1
BIOLOGICAL: HPVDC injection level dose 2
BIOLOGICAL: placebo injection level dose 2

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]